JP2008525033A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525033A5
JP2008525033A5 JP2007548453A JP2007548453A JP2008525033A5 JP 2008525033 A5 JP2008525033 A5 JP 2008525033A5 JP 2007548453 A JP2007548453 A JP 2007548453A JP 2007548453 A JP2007548453 A JP 2007548453A JP 2008525033 A5 JP2008525033 A5 JP 2008525033A5
Authority
JP
Japan
Prior art keywords
nucleic acid
polypeptide
group
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007548453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525033A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/046491 external-priority patent/WO2006069200A2/en
Publication of JP2008525033A publication Critical patent/JP2008525033A/ja
Publication of JP2008525033A5 publication Critical patent/JP2008525033A5/ja
Pending legal-status Critical Current

Links

JP2007548453A 2004-12-22 2005-12-21 Ｂ群連鎖球菌 Pending JP2008525033A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63894304P 2004-12-22 2004-12-22
US64043804P 2004-12-30 2004-12-30
PCT/US2005/046491 WO2006069200A2 (en) 2004-12-22 2005-12-21 Group b streptococcus

Publications (2)

Publication Number Publication Date
JP2008525033A JP2008525033A (ja) 2008-07-17
JP2008525033A5 true JP2008525033A5 (enExample) 2009-07-23

Family

ID=36602309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548453A Pending JP2008525033A (ja) 2004-12-22 2005-12-21 Ｂ群連鎖球菌

Country Status (8)

Country Link
US (1) US20090104218A1 (enExample)
EP (1) EP1828231A2 (enExample)
JP (1) JP2008525033A (enExample)
AU (1) AU2005319174A1 (enExample)
CA (1) CA2591510A1 (enExample)
IL (1) IL183830A0 (enExample)
MX (1) MX2007007033A (enExample)
WO (1) WO2006069200A2 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
EA004444B1 (ru) 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
ES2330083T3 (es) 2000-10-27 2009-12-04 Novartis Vaccines And Diagnostics S.R.L. Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
ES2505695T3 (es) 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
EP1801235A1 (en) * 2005-12-20 2007-06-27 Institut Pasteur Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
WO2008020308A2 (en) * 2006-06-19 2008-02-21 Mutabilis Sa Identification of genes implicated in the virulence of streptococcus agalactiae
US20100150943A1 (en) * 2006-07-26 2010-06-17 Novartis Ag Immunogenic compositions for gram positive bacteria
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
EP2135877A1 (en) 2008-06-19 2009-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
US8147849B2 (en) 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
IN2012DN00791A (enExample) 2009-06-29 2015-06-26 Genocea Biosciences Inc
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
JP6126993B2 (ja) 2011-01-20 2017-05-10 ジェノセア バイオサイエンシーズ， インコーポレイテッド 肺炎連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）に対するワクチン及び組成物
WO2012105595A1 (ja) * 2011-02-02 2012-08-09 公益財団法人微生物化学研究会 血液脳関門を透過する薬物輸送体、ペプチド及びその用途
EP2557424A1 (en) 2011-08-11 2013-02-13 InGen Biosciences Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
RU2014138418A (ru) * 2012-02-24 2016-04-10 Новартис Аг Белки пилей и композиции
JP6335873B2 (ja) * 2012-03-30 2018-05-30 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ 過酸生成に有用な酵素
ES2690526T3 (es) 2012-10-03 2018-11-21 Glaxosmithkline Biologicals S.A. Composiciones inmunogénicas
WO2015008214A1 (en) * 2013-07-16 2015-01-22 Universite De Lausanne Bacterial lysins and uses thereof
EA201790239A1 (ru) * 2014-08-05 2017-07-31 Глаксосмитклайн Байолоджикалс С.А. Молекула-носитель для антигенов
EP3411389B1 (en) 2016-02-04 2021-03-24 Genovis Ab New streptococcal proteases
US11028159B2 (en) 2017-05-02 2021-06-08 Venomyx, Inc. Composition and methods for treating snake envenomation
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same
PL239045B1 (pl) * 2018-01-09 2021-11-02 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
GB2597566B (en) * 2018-06-13 2023-02-01 Gen Probe Inc Compositions and methods for detecting group B streptococcus nucleic acid
WO2020033312A1 (en) 2018-08-06 2020-02-13 Medikine, Inc. Il-2 receptor binding compounds
JP7427286B2 (ja) 2019-11-05 2024-02-05 メディカイン、インコーポレイテッド ＩＬ－２ＲβγＣ結合化合物
CN114980932A (zh) * 2019-12-06 2022-08-30 瑟瑞技术公司 Sortilin结合缀合化合物、其组合物及其用于治疗癌症的用途
KR20220139918A (ko) 2020-02-03 2022-10-17 메디카인 인코포레이티드 IL-7Rαγc 결합 화합물
WO2021163584A1 (en) * 2020-02-12 2021-08-19 The Broad Institute, Inc. Field deployable crispr-cas diagnostics and methods of use thereof
US11639523B2 (en) 2020-03-23 2023-05-02 The Broad Institute, Inc. Type V CRISPR-Cas systems and use thereof
WO2022026534A1 (en) * 2020-07-28 2022-02-03 Kansas State University Research Foundation Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
IL302575A (en) * 2020-11-04 2023-07-01 Medikine Inc IL-2R BETA GAMMA c BINDING COMPOUNDS AND USES THEREOF
US11999771B2 (en) 2022-04-07 2024-06-04 Medikine, Inc. IL-7Rαγc ligand immunoglobulin fusion proteins
WO2025017062A1 (en) * 2023-07-18 2025-01-23 Intervet International B.V. New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
WO2025151408A1 (en) * 2024-01-08 2025-07-17 Denali Therapeutics Inc. Compositions and methods for modulating tau expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
ES2330083T3 (es) * 2000-10-27 2009-12-04 Novartis Vaccines And Diagnostics S.R.L. Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
EP2314603A3 (en) * 2002-10-15 2011-05-18 Intercell AG Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and futher uses thereof
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741

Similar Documents

Publication Publication Date Title
JP2008525033A5 (enExample)
JP2008538183A5 (enExample)
JP2012000112A5 (enExample)
RU2007139915A (ru) Haemophilus influenzae типа в
JP2010166916A5 (enExample)
RU2006144093A (ru) Полипептиды нетипируемой haemophilus influenzae
JP2008529558A5 (enExample)
JP2005511076A5 (enExample)
JP2003527079A5 (enExample)
JP2010273685A5 (enExample)
JP2008508859A5 (enExample)
JP2012505657A5 (enExample)
RU2012102339A (ru) Полипептиды из neisseria meningitidis
JP2011004753A5 (enExample)
JP2012126742A5 (enExample)
JP2010532657A5 (enExample)
JP2002542827A5 (enExample)
JP2012115277A5 (enExample)
JP2007502101A5 (enExample)
EP2292647A3 (en) Small Streptococcus pyogenes antigens and their use
JP2015514132A5 (enExample)
JP2013523718A5 (enExample)
JP2019534884A5 (enExample)
JP2010517544A5 (enExample)
JP2015119721A5 (enExample)